日本BD(日本ベクトン・ディッキンソン株式会社 本社:東京都港区、代表取締役社長:長瀬信弥)は、3月8日(土)の国際女性デーに先駆けて「WE HOPE ~子宮頸がんをなくそうプロジェクト~ 」を始動しました。本プロジェクトは、子宮頸がん検診受診率の向上と高感度スクリーニング検査方法といわれるHPV検査* の認知向上を目的としており、今後、社内外で複数の活動を進めていきます。
プレスリリース
The next-generation Closed-System Drug-Transfer Device (CSTD) from BD that advances hazardous drug protection
Choose pre-filled flush syringes you can rely on.
Enhance medication availability while increasing security and control of medications and supplies with a comprehensive system of automated dispensing solutions and pharmacy technologies across your healthcare system.
Leading the way in effective pre-op skin prep.
Reduced accidental needlesticks.
Delivering efficiency, flexibility, and performance to meet your laboratories' evolving molecular diagnostic needs.
Derive greater insights and unlock new discoveries using image-enabled sorting and spectral flow cytometry.
Fully resorbable implant for soft tissue reconstruction.
Preserving sites and protecting veins.
The activated hyperlink may be to a third-party website. Clicking on the link may allow third parties to collect or share data about you. We do not control these third-party websites and are not responsible for their privacy statements. When you leave this website, we encourage you to read the privacy notice of every website you visit.
Where the website is managed by another BD company, please note that it may be governed by different laws and policies, and may feature products and services that are not available locally. Please contact your local BD representative if you have any questions or should you require further support.